DeepMed Research

Hamilton Health Sciences Corporation

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Postop Pain Management in Pituitary Tumour Patients

Phase 4

Recruiting

Conditions: Pituitary
Pain, Postoperative

Interventions: Drug: Placebo
Drug: Sham Comparator

First Posted Date: 2024-04-09

Last Posted Date: 2025-03-18

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 108

Registration Number: NCT06353529

Locations: 🇨🇦
Hamilton General Hospital, Hamilton, Ontario, Canada

Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial

Phase 3

Not yet recruiting

Conditions: Surgery
Chronic Kidney Diseases
Acute Kidney Injury
Bleeding

Interventions: Drug: Desmopressin Injectable Solution
Drug: Tranexamic Acid Injectable Product
Other: Placebo

First Posted Date: 2024-03-29

Last Posted Date: 2025-05-21

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 100

Registration Number: NCT06337838

Inflammation REduction to Prevent CArdiovascular Injury in Renal Disease (REPAIR)

Phase 1

Recruiting

Conditions: Renal Failure
Chronic Kidney Diseases

Interventions: Drug: Colchicine

First Posted Date: 2024-01-12

Last Posted Date: 2025-03-12

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 200

Registration Number: NCT06203977

Locations: 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
🇨🇦
St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada
🇨🇦
London Health Sciences Centre, London, Ontario, Canada

Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy

Phase 2

Recruiting

Conditions: Arrhythmogenic Cardiomyopathy
Arrhythmogenic Right Ventricular Cardiomyopathy

Interventions: Drug: Placebo
Drug: Tideglusib

First Posted Date: 2023-12-18

Last Posted Date: 2025-04-03

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 120

Registration Number: NCT06174220

Locations: 🇨🇦
Foothills Medical Centre, Calgary, Alberta, Canada
🇨🇦
St. Paul's Hospital, Vancouver, British Columbia, Canada
🇨🇦
Victoria Cardiac Arrhythmia Trials Inc., Victoria, British Columbia, Canada

and more 14 locations

Novel Donor Site Dressing (Product X)

Not Applicable

Not yet recruiting

Conditions: Burns

Interventions: Device: Product X
Device: Standard-of-Care

First Posted Date: 2023-12-11

Last Posted Date: 2024-10-02

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 40

Registration Number: NCT06163742

Locations: 🇨🇦
Hamilton General Hospital, Hamilton, Ontario, Canada

Early Versus Late Upper Extremity Mobilization After Meshed / Sheet Split Thickness Skin Autograft on Wound Healing in Adult Burn Patients

Not Applicable

Not yet recruiting

Conditions: Burns

Interventions: Procedure: Early Mobilization
Procedure: Late Mobilization

First Posted Date: 2023-11-22

Last Posted Date: 2023-12-08

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 100

Registration Number: NCT06143683

Infection Prophylaxis in Total Joint Replacement

Phase 3

Recruiting

Conditions: Periprosthetic Joint Infection

Interventions: Other: Saline
Other: Povidone-Iodine
Drug: Vancomycin Hydrochloride
Drug: Chlorhexidine Gluconate

First Posted Date: 2023-11-13

Last Posted Date: 2024-08-21

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 21006

Registration Number: NCT06126614

Locations: 🇨🇦
Hamilton Health Sciences - Juravinski Hospital and Cancer Centre, Hamilton, Ontario, Canada

Chronic Cancer Pain Management Program

Not Applicable

Recruiting

Conditions: Pain Cancer
Breast Cancer
Cancer, Treatment-Related

Interventions: Behavioral: I-Can-Manage-Pain after cancer (Pain Management Program)

First Posted Date: 2023-10-26

Last Posted Date: 2024-03-01

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 30

Registration Number: NCT06101849

Locations: 🇨🇦
Juravinski Cancer Centre, Hamilton, Ontario, Canada

Supplementation for Male Subfertility

Phase 2

Not yet recruiting

Conditions: Male Infertility

Interventions: Dietary Supplement: Active multi-ingredient supplement (Fertility Enhancer, FE)
Dietary Supplement: Inactive placebo (Placebo; PLA)

First Posted Date: 2023-10-23

Last Posted Date: 2024-10-10

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 64

Registration Number: NCT06091969

Locations: 🇨🇦
Mark Tarnopololsky, Hamilton, Ontario, Canada

Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma

Phase 2

Not yet recruiting

Conditions: Vulvar Cancer

Interventions: Procedure: ICG alone

First Posted Date: 2023-09-15

Last Posted Date: 2023-09-15

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 58

Registration Number: NCT06039111

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy